title: HCV genotypes and breakthrough in patients treated with recombinant alpha interferon.
authors.forename: L
authors.initials: L
authors.lastname: Roffi
authors.forename: G
authors.initials: G
authors.lastname: Colloredo
authors.forename: B
authors.initials: B
authors.lastname: Brugnetti
authors.forename: G
authors.initials: G
authors.lastname: Bellati
authors.forename: A
authors.initials: A
authors.lastname: Ricci
authors.forename: A
authors.initials: A
authors.lastname: Scalori
authors.forename: G
authors.initials: G
authors.lastname: Antonelli
authors.forename: F
authors.initials: F
authors.lastname: Panizzuti
authors.forename: M
authors.initials: M
authors.lastname: Pozzi
authors.forename: P
authors.initials: P
authors.lastname: Pioltelli
authors.forename: G
authors.initials: G
authors.lastname: Mancia
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood*; D000914:Antibodies, Viral / Q000378:metabolism; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000201:enzymology*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D000410:Alanine Transaminase